NasdaqGS - Nasdaq Real Time Price USD

National Research Corporation (NRC)

Compare
18.62 -0.13 (-0.69%)
As of 10:20 AM EST. Market Open.
Loading Chart for NRC
DELL
  • Previous Close 18.75
  • Open 18.75
  • Bid 18.44 x 100
  • Ask 19.08 x 100
  • Day's Range 18.62 - 18.79
  • 52 Week Range 17.62 - 42.19
  • Volume 3,670
  • Avg. Volume 73,967
  • Market Cap (intraday) 437.123M
  • Beta (5Y Monthly) 0.53
  • PE Ratio (TTM) 16.62
  • EPS (TTM) 1.12
  • Earnings Date Oct 25, 2024
  • Forward Dividend & Yield 0.48 (2.56%)
  • Ex-Dividend Date Dec 27, 2024
  • 1y Target Est --

National Research Corporation provides analytics and insights that facilitate measurement and enhancement of the patient and employee experience. Its portfolio of subscription-based solutions provides actionable information and analysis to healthcare organizations across a range of mission-critical, constituent-related elements, including patient experience, service recovery, care transitions, employee engagement, reputation management, and brand loyalty. The company also offers marketing solutions that allow the tracking of awareness, perception, and consistency of healthcare brands; assessment of competitive differentiators; and enhanced segmentation tools to evaluate needs, wants, and behaviors of communities through real-time competitive assessments and enhanced segmentation tools. In addition, it provides experience solutions, such as patient experience, employee engagement, health risk assessments, care transition, and improvement tools. Further, the company provides reputation solutions that allow healthcare organizations to share a picture of their organization and ensure that timely and relevant content informs consumer decision-making; and governance solutions for not-for-profit hospital and health system boards of directors, executives, and physician leadership. National Research Corporation was founded in 1981 and is headquartered in Lincoln, Nebraska.

www.nrchealth.com

435

Full Time Employees

December 31

Fiscal Year Ends

Recent News: NRC

View More

Performance Overview: NRC

Trailing total returns as of 11/21/2024, which may include dividends or other distributions. Benchmark is

.

YTD Return

NRC
52.29%
S&P 500
23.54%

1-Year Return

NRC
54.90%
S&P 500
29.59%

3-Year Return

NRC
53.01%
S&P 500
25.43%

5-Year Return

NRC
67.72%
S&P 500
89.57%

Compare To: NRC

Select to analyze similar companies using key performance metrics; select up to 4 stocks.

Statistics: NRC

View More

Valuation Measures

Annual
As of 11/20/2024
  • Market Cap

    440.18M

  • Enterprise Value

    490.35M

  • Trailing P/E

    16.74

  • Forward P/E

    --

  • PEG Ratio (5yr expected)

    --

  • Price/Sales (ttm)

    3.13

  • Price/Book (mrq)

    12.71

  • Enterprise Value/Revenue

    3.40

  • Enterprise Value/EBITDA

    11.31

Financial Highlights

Profitability and Income Statement

  • Profit Margin

    18.79%

  • Return on Assets (ttm)

    18.53%

  • Return on Equity (ttm)

    58.56%

  • Revenue (ttm)

    144.16M

  • Net Income Avi to Common (ttm)

    27.08M

  • Diluted EPS (ttm)

    1.12

Balance Sheet and Cash Flow

  • Total Cash (mrq)

    3.46M

  • Total Debt/Equity (mrq)

    156.84%

  • Levered Free Cash Flow (ttm)

    21.74M

Research Analysis: NRC

View More

Analyst Price Targets

 

Company Insights: NRC

People Also Watch